Different interactions between MT7 toxin and the human muscarinic M 1 receptor in its free and N-methylscopolamine-occupied states

Molecular Pharmacology

Volumn 74, Issue 6, 2008, Pages 1554-1563

  Fruchart Gaillard, Carole ^a   Mourier, Gilles ^a   Marquer, Catherine ^a   Stura, Enrico ^a   Birdsall, Nigel J M ^b   Servent, Denis ^a  

^a SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DIIODOMUSCARINIC TOXIN 7; METHIONINE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; MUSCARINIC TOXIN 7; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING KINETICS; BINDING SITE; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DISSOCIATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY; STRUCTURE ACTIVITY RELATION; TOXIN STRUCTURE;

EID: 57349143427     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.050773     Document Type: Article

References (33)

1. Bourne Y, Talley TT, Hansen SB, Taylor P, and Marchot P (2005) Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors. EMBO J 24:1512-1522.
2. Bourne Y, Taylor P, and Marchot P (1995) Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex. Cell 83:503-512.
3. Bradley KN (2000) Muscarinic toxins from the green mamba. Pharmacol Ther 85:87-109.
4. Carsi JM and Potter LT (2000) m1-toxin isotoxins from the green mamba (Dendroaspis angusticeps) that selectively block m1 muscarinic receptors. Toxicon 38:187-198.
5. Christopoulos A and Kenakin T (2002) G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54:323-374.
6. Christopoulos A, Lanzafame A, and Mitchelson F (1998) Allosteric interactions at muscarinic cholinoceptors. Clin Exp Pharmacol Physiol 25:185-194.
7. Ehlert FJ (1988) Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol Pharmacol 33:187-194.
8. Ellis J, Seidenberg M, and Brann MR (1993) Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol Pharmacol 44:583-588.
9. Fruchart-Gaillard C, Gilquin B, Antil-Delbeke S, Le Novère N, Tamiya T, Corringer PJ, Changeux JP, Ménez A, and Servent D (2002) Experimentally-based model of a complex between a snake toxin and the α7 nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A 99:3216-3221.
10. 125I-Met35-oxidized muscarinic toxin 7. Mol Pharmacol 69:1641-1651.
11. Gharagozloo P, Lazareno S, Miyauchi M, Popham A, and Birdsall NJM (2002) Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships. J Med Chem 45: 1259-1274.
12. Gnagey AL, Seidenberg M, and Ellis J (1999) Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors. Mol Pharmacol 56:1245-1253.
13. Karlsson E, Jolkkonen M, Mulugeta E, Onali P, and Adem A (2000) Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors. Biochimie 82:793-806.
14. 1 muscarinic receptors. Mol Pharmacol 60:725-731.
15. Kukkonen A, Peräkylä M, Akerman KE, and Näsman J (2004) Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops. J Biol Chem 279:50923-50929.
16. Lazareno S and Birdsall NJ (1995) Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48:362-378.
17. 3H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site. Mol Pharmacol 58:194-207.
18. Marchot P, Prowse CN, Kanter J, Camp S, Ackermann EJ, Radić Z, Bougis PE, and Taylor P (1997) Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom. J Biol Chem 272:3502-3510.
19. Matsui H, Lazareno S, and Birdsall NJM (1995) Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. Mol Pharmacol 47:88-98.
20. Max SI, Liang JS, and Potter LT (1993) Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol Pharmacol 44:1171-1175.
21. McRee DE (1999) XtalView/Xfit-A versatile program for manipulating atomic coordinates and electron density. J Struct Biol 125:156-165.
22. Ménez R and Ducruix A (1993) A toxin that recognizes muscarinic acetylcholine receptors. Preparation and characterization of crystals suitable for structural analysis. J Mol Biol 232:997-998.
23. Mourier G, Dutertre S, Fruchart-Gaillard C, Ménez A, and Servent D (2003) Chemical synthesis of MT1 and MT7 muscarinic toxins: critical role of Arg-34 in their interaction with M1 muscarinic receptor. Mol Pharmacol 63:26-35.
24. Mourier G, Servent D, Zinn-Justin S, and Ménez A (2000) Chemical engineering of a three-fingered toxin with anti-a7 neuronal acetylcholine receptor activity. Protein Engineering 13:217-225.
25. Murshudov GN, Vagin AA, and Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53:240-255.
26. Näsman J, Jolkkonen M, Ammoun S, Karlsson E, and Akerman KE (2000) Recombinant expression of a selective blocker of M(1) muscarinic receptors. Biochem Biophys Res Commun 271:435-439.
27. Olianas MC, Adem A, Karlsson E, and Onali P (2004) Action of the muscarinic toxin MT7 on agonist-bound muscarinic M1 receptors. Eur J Pharmacol 487:65-72.
28. Olianas MC, Maullu C, Adem A, Mulugeta E, Karlsson E, and Onali P (2000) Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7). Br J Pharmacol 131:447-452.
29. Otwinowski Z and Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326.
30. Ségalas I, Roumestand C, Zinn-Justin S, Gilquin B, Ménez R, Ménez A, and Toma F (1995) Solution structure of a green mamba toxin that activates muscarinic acetylcholine receptors, as studied by nuclear magnetic resonance and molecular modeling. Biochemistry 34:1248-1260.
31. Servent D and Ménez A (2001) Snake neurotoxins that interact with nicotinic acetylcholine receptors, in Handbook of Neurotoxicology (Massaro EJ ed) pp 385-425, Humana Press Inc., Totowa, NJ.
32. Stockton JM, Birdsall NJ, Burgen AS, and Hulme EC (1983) Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol 23:551-557.
33. Vagin A and Teplyakov A (1997) MOLREP: an automated program for molecular replacement. J Appl Crystallogr 30:1022-1025.